knowledge -WSS

knowledge

author：fashion 2025-10-04 11:35:22 - browse：591

Jamy Ard (left) and Robert Lustig (right) on the 2023 STAT Breakthrough Summit stage -- coverage from STAT — Obesity experts Jamy Ard (left) and Robert Lustig speak at a panel during the 2023 STAT Breakthrough Summit. Sarah Gonzalez for STAT

Amid rising demand for drugs like Wegovy, Ozempic, and Mounjaro that can lead to significant weight loss, some obesity experts are concerned about the drugs’ costs — both to patients’ finances and to their health.

Speaking at a panel on new obesity treatments at the STAT Breakthrough Summit in San Francisco on Thursday, one expert cited a large clinical trial for Wegovy that showed that about 40% of the weight participants lost was lean mass. Side effects like nausea, vomiting, and a possible link to rare cases of pancreatitis also still plague this newest class of drugs, which imitate the effects of a hormone called glucagon-like peptide 1 (GLP) that helps people feel full.

“That’s what starvation does. You lose equal amounts of muscle and fat,” said Robert Lustig, emeritus professor of pediatrics at the University of California, San Francisco. “If you’re a person 60 years old or over and you’re losing muscle, your risk of dying just went up exponentially. So we may be … robbing Peter to pay Paul.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： Quicker fix for pulse oximeters urged during FDA public meeting

WSS

In a test for AI, buzzy startup Insitro inks drug discovery deal with Gilead

Stop the failed accountable care organization experiment

Apple Vision Pro: A first look at health apps on the new VR headset

Intermittent fasting comes with a heart risk? Not so fast

Future doctors should be trained to promote social change

What we need to know about Arena Bioworks

hotspot

knowledge

entertainment

Drug repurposing or repositioning? The language matters

In a test for AI, buzzy startup Insitro inks drug discovery deal with Gilead

Dobbs anniversary: the lost opportunity of abortion as health care

U.K. researchers warn about biases in medical devices, algorithms

New air purifier tech could be key to improving indoor air quality

Cybersecurity threat forces Lurie Children's to take systems offline

Trump demands the U.S. pay no more for drugs than other countries … again

Virtual Event: March of the Biosimilars

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Do digital therapeutics have a future in medicine?

entertainment

The real point of Kenneth Smith’s execution by nitrogen gas

Covid misinformation case heads to Supreme Court

A $475,000 price tag for a new cancer drug: crazy or meh?

Vertigo drug brings hope for rare neuron disorder, Niemann

Some dementia cases could be undiagnosed liver disease

Congressmen charge Covid hearing ‘could have been an email’

explore

explore

hotspot

focus